Priya PatelLet’s see what’s in the news today.
Autodesk Executives Ignored Accounting Risks, Documents Show
Autodesk Inc. continued to use a controversial sales strategy after promising investors it would stop and ignored internal warnings about the risks of doing so, according to previously unreported internal documents.
Read the original article here
Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced the appointment of life sciences accounting and finance veteran David House as Senior Vice President, Finance, effective August 16th. Armata’s Corporate Controller, Richard Rychlik, will retain the position of Controller.
Read the original article here
Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
Armata Pharmaceuticals appoints David House as SVP Finance, bolstering leadership for pivotal studies. Learn how his extensive life sciences experience will advance key programs AP-PA02 and AP-SA02.
Read the original article here
– Company Announcement
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. Read the original article here
Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
/PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on the development of…
Read the original article here
